Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 40kWORD 21k
30 October 2019
P-003556-19
Question for written answer P-003556-19
to the Commission
Rule 138
Mounir Satouri (Verts/ALE)

 Subject:  Recognition of multiple chemical sensitivity

Multiple chemical sensitivity is a chronic, serious and debilitating condition for which there is no specific treatment or support with regard to medical expenses.

It can cause physical impairment that can in turn result in isolation and exclusion. The root causes of multiple chemical sensitivity are not known, owing to a lack of appropriate research.

The condition affects 11% of the world’s population and is reportedly increasing sharply.

What is the Commission doing to:
1. Encourage the Member States to submit a joint proposal to the World Health Organisation with a view to having multiple chemical sensitivity included on the international classification of diseases, as called for during the review of that classification (ICD-11)?
2. Promote research, awareness-raising and exchange of information on multiple chemical sensitivity at EU level?
3. Promote the establishment of areas to provide respite in serious emergencies?
Original language of question: FR 
Last updated: 31 October 2019Legal notice